Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
Clinical trial NCT01976741 · COMPLETED
Trial details
- NCT number
- NCT01976741
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-30
- Primary completion
- 2019-03-11
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.